Thus, we have investigated: (1) the abundance of IL-37 in the blood of control and ischemic stroke patients, and in post-mortem brain sections; and (2) the effect of IL-37 on stroke outcome measures in mice transgenic for human IL-37 (IL-37tg). Here, IL37 is linked to stroke disorder.